21.5 C
New York
Saturday, June 3, 2023

Are Things Looking Up For Poseida Therapeutics Inc. (NASDAQ: PSTX)?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Poseida Therapeutics Inc. (PSTX) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.03, or 1.06%, to $2.85. The Poseida Therapeutics Inc. has recorded 5,535 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Poseida Therapeutics to Present at 31st Congress of the International Society on Thrombosis and Haemostasis.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $2.82 and fluctuated between $2.9250 as its day high and $2.5300 as its day low. The current market capitalization of Poseida Therapeutics Inc. is $239.05M. A total of 0.66 million shares were traded on the day, compared to an average of 751.60K shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, PSTX has seen 6 BUY and 3 SELL insider trades, representing the acquisition of 944,038 and the disposition of 35,263 shares. Over the last 12 months, there were 13 BUYs and 6 SELLs from insiders. Insiders purchased 3,354,795 shares during that period but sold 239,554.

In the most recent transaction, Malin Life Sciences Holdings L bought 2,150,000 shares of PSTX for 3.50 per share on Aug 08. After the transaction, the 10% Owner now owns 11,835,673 company shares. In a previous transaction on Aug 08, Ostertag Eric bought 142,857 shares at 3.50 per share. PSTX shares that Executive Chairman owns now total 838,824.

Among the insiders who sold shares, Ostertag Eric disposed of 160,696 shares on Aug 03 at a per-share price of $3.69. This resulted in the Executive Chairman holding 0 shares of PSTX after the transaction.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for PSTX in the last 3 months, the mean price target is $13.40 with high estimates of $17.00 and low estimates of $10.00. In terms of 52-week highs and lows, PSTX has a high of $8.82 and a low of $1.82.

As of this writing, PSTX has an earnings estimate of -$0.55 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.49 per share and a lower estimate of -$0.6. The company reported an EPS of -$0.39 in the last quarter, which was -77.30% lower than expectations of -$0.22.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. PSTX’s latest balance sheet shows that the firm has $206.32M in Cash & Short Term Investments as of fiscal 2021. There were $61.20M in debt and $43.34M in liabilities at the time. Its Book Value Per Share was $1.83, while its Total Shareholder’s Equity was $156.21M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PSTX is Buy with a score of 5.00.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles